Clinical Trial Update: Placebo vs. Linoleic Acid Controlled Assessment of Treatment Efficacy in MS [Phase 1]

View source ↗

Summary

A Phase 1 trial comparing placebo to linoleic acid for treating multiple sclerosis was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Linoleic acid (linoleic acid)

Snippet

Sponsor: University of Rochester | Conditions: Multiple Sclerosis | Phase 1 | Status: TERMINATED